Drug intelligence / Profile preview

Azathioprine + Calcitriol + Methylprednisolone

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

The combination "azathioprine + calcitriol + methylprednisolone" represents a multi-drug regimen rather than a single branded combination product. Each component has distinct mechanisms of action and uses, though they may be prescribed together in certain clinical scenarios. ## Azathioprine Azathioprine is an immunosuppressant prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings[3]. It's used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection[3]. Azathioprine received FDA approval on March 20, 1968[3]. ## Methylprednisolone Methylprednisolone is a corticosteroid used to treat inflammation or immune reactions across various organ systems[1]. Its primary use is to suppress inflammatory and immune responses by regulating the number and function of leukocytes, cytokines, and chemokines[7]. It's commonly prescribed as short-term therapy for acute flares, such as in acute gouty arthritis[7]. ## Combination Use The combination of azathioprine and corticosteroids (like methylprednisolone) has been studied in various conditions: 1. **Rheumatoid Arthritis**: Methylprednisolone pulse therapy in conjunction with azathioprine has shown a short-lasting beneficial effect in persistently active rheumatoid arthritis[2]. 2. **Serpiginous Choroiditis**: When azathioprine is used in combination with corticosteroids, it has been found to be a safe and acceptable option for treating patients with active serpiginous choroiditis[5]. 3. **Renal Transplantation**: Azathioprine was initially used in combination with prednisolone as 'double therapy' for renal transplantation[6]. 4. **Lupus Nephritis**: In severe manifestations of Systemic Lupus Erythematosus, patients are often prescribed methylprednisolone concomitantly with immunosuppressants, and maintenance therapy may include oral prednisolone and azathioprine[7].

02

Targets

VDR (Vitamin D receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Azathioprine + Calcitriol + Methylprednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azathioprine + Calcitriol + Methylprednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call